{"id":8995,"date":"2023-10-12T07:54:39","date_gmt":"2023-10-12T07:54:39","guid":{"rendered":"https:\/\/sitpharma.com\/italy\/?p=8995"},"modified":"2023-10-12T07:56:16","modified_gmt":"2023-10-12T07:56:16","slug":"sit-acquires-potasion-from-sanofi","status":"publish","type":"post","link":"https:\/\/sitpharma.com\/italy\/en\/news-eng\/sit-acquires-potasion-from-sanofi\/","title":{"rendered":"Sit Acquires Potasion From Sanofi"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Sit Acquires Potasion From Sanofi\n\n\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.\u00a0<\/span><\/p>
This additional acquisition in Spain market increases DESMA Spain\u2019s footprint and business.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.\u00a0<\/p>\n","protected":false},"author":1,"featured_media":6458,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[95],"tags":[],"class_list":["post-8995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-eng"],"yoast_head":"\n
Sit Acquires Potasion From Sanofi - Sitpharma - Italia<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\t\n